TSPO and Alzheimer disease: In vivo imaging methods, particularly translocator protein positron emission tomography (TSPO-PET) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), have advanced our understanding of glial activation and BBB permeability in conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, Huntington’s disease, schizophrenia, and depression.